• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Malaria

    Malaria: New chemical formulation for bed nets shows promising results

    Mosquito resistance to pyrethroids — the key chemical ingredient used in insecticide-treated bed nets — had researchers looking to adjust to the formula. Now, they may have done it.

    By Jenny Lei Ravelo // 22 November 2019
    An insecticide-treated bed net with piperonyl butoxide being assessed in Uganda in 2018. Photo by: LSTM

    MANILA — Long-lasting insecticide-treated bed nets have been a lifesaving tool against malaria, but increased resistance against pyrethroids — the key chemical ingredient used — had researchers looking for alternatives or adjustments. Now, they may have found one.

    In a major trial in Uganda, researchers found that although traditional pyrethroid-treated bed nets continue to be effective, households given bed nets with a combination of pyrethroids and the chemical piperonyl butoxide experienced 27% fewer cases of malaria among children ages 2 to 10. These households also had 80% fewer malaria-carrying mosquitoes.

    “We need to guard against complacency, mosquito genomes are highly diverse, and it is almost inevitable that resistance will emerge.”

    — Martin Donnelly, head of vector biology department, Liverpool School of Tropical Medicine

    “The results from Uganda show that by using an insecticide formulation that interferes with the mechanisms mosquitoes use to defeat pyrethroids, we are seeing a significant restoration of pyrethroid efficacy — not back to pre-resistance levels, but enough to buy us critically needed time while we develop new insecticides and interventions,” said Martin Donnelly, co-leader of the evaluation project. The results of the trial were presented Thursday at the annual meeting of the American Society of Tropical Medicine and Hygiene.

    Nets with piperonyl butoxide have been used on a small scale in countries such as Tanzania, but Donnelly told Devex that many health ministers in Africa are awaiting clear guidelines from the World Health Organization.

    The combination formula received a conditional recommendation from WHO in 2017, and its Vector Control Advisory Group is expected to make another assessment in 2020 to determine whether to provide a full recommendation for the intervention.

    How genetic modification in mosquitoes could accelerate malaria elimination efforts

    The success of a recent experiment offers a potential pathway.

    Other insecticide-treated nets under review by the WHO advisory group include one containing a combination of pyrethroid and chlorfenapyr, an insecticide used in agriculture; and another with pyrethroid and pyriproxyfen, an insect growth regulator that sterilizes female mosquitoes.

    “Staff at the Liverpool School of Tropical Medicine are also looking at redesigning the shape of the nets to exploit mosquito behavior — mosquitoes commonly land first on the top surface of nets,” Donnelly added.

    But he stressed that the aid and research community must continue searching for long-term solutions.

    “There are already pyrethroid resistance mechanisms in the vector populations which are not affected by [piperonyl butoxide],” said Donnelly, who is an expert in the genetics of insecticide resistance at the Liverpool School of Tropical Medicine.

    “Our message is that we need to guard against complacency, mosquito genomes are highly diverse, and it is almost inevitable that resistance will emerge,” he said.

    There have been increasing concerns about the impact of pyrethroid resistance on anti-malaria efforts globally. Donnelly said it’s hard to quantify, but WHO reports in recent years have shown stagnation in global progress against malaria, which “is at least partially coincident with observed increases in pyrethroid resistance,” he said.

    Emphasizing the importance of insecticide-treated bed nets in the fight against malaria, Donnelly said that “between 2000 and 2015, an estimated 215 [million] cases of malaria were averted by three interventions. It is estimated that [insecticide-treated bed nets] were responsible for [approximately] 68% of this total.”

    There were 219 million malaria cases globally in 2017, an increase from 216 million in 2016 and 212 million in 2015.

    • Global Health
    • Research
    • WHO
    • LSTM
    • Uganda
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    Malaria'Malaria thrives on chaos' — and the US aid freeze is creating it

    'Malaria thrives on chaos' — and the US aid freeze is creating it

    Sponsored by GSKInside the science shaping the next generation of malaria vaccines

    Inside the science shaping the next generation of malaria vaccines

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      The legal case threatening to upend philanthropy's DEI efforts
    • 3
      Why most of the UK's aid budget rise cannot be spent on frontline aid
    • 4
      How is China's foreign aid changing?
    • 5
      2024 US foreign affairs funding bill a 'slow-motion gut punch'
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement